Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and...
Main Author: | |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2019
|